Traws Pharma (TRAW) Minority Interest (2013 - 2018)
Traws Pharma (TRAW) posted quarterly Minority Interest of $830000.0 for Q1 2018, little changed year-over-year from $830000.0 in Q1 2017, and little changed quarter-over-quarter from $830000.0 in Q4 2017.
Traws Pharma (TRAW) Minority Interest (2013 - 2018) Analysis & Trends
Traws Pharma (TRAW) has reported Minority Interest for 6 consecutive years, with $830000.0 the latest figure, recorded in Q1 2018.
- In Q1 2018, Minority Interest changed 0.0% year-over-year to $830000.0; the TTM figure through Mar 2018 stood at $830000.0 (changed 0.0% YoY), while the FY2017 annual figure was $830000.0, changed 0.0% from the prior year.
- Minority Interest steadied at $830000.0 in Q1 2018 per TRAW's latest filing, from $830000.0 in the prior quarter.
- Across five years, Minority Interest topped out at $874000.0 in Q4 2014 and bottomed at $394000.0 in Q3 2014.
- Historically, Minority Interest has averaged $761823.5 across 5 years, with a median of $830000.0 in 2015.
- On a YoY basis, Minority Interest climbed as much as 110.66% in 2015 and fell as far as 5.03% in 2015.
- Traws Pharma's Minority Interest stood at $874000.0 in 2014, then slipped by 5.03% to $830000.0 in 2015, then changed by 0.0% to $830000.0 in 2016, then changed by 0.0% to $830000.0 in 2017, then changed by 0.0% to $830000.0 in 2018.
- Business Quant data shows TRAW's Minority Interest at $830000.0 in Q1 2018, $830000.0 in Q4 2017, and $830000.0 in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 830,000.00 |
| Dec 31, 2017 | 830,000.00 |
| Sep 30, 2017 | 830,000.00 |
| Jun 30, 2017 | 830,000.00 |
| Mar 31, 2017 | 830,000.00 |
| Dec 31, 2016 | 830,000.00 |
| Sep 30, 2016 | 830,000.00 |
| Jun 30, 2016 | 830,000.00 |
| Mar 31, 2016 | 830,000.00 |
| Dec 31, 2015 | 830,000.00 |
| Sep 30, 2015 | 830,000.00 |
| Jun 30, 2015 | 830,000.00 |
| Mar 31, 2015 | 850,000.00 |
| Dec 31, 2014 | 874,000.00 |
| Sep 30, 2014 | 394,000.00 |
| Jun 30, 2014 | 423,000.00 |
| Mar 31, 2014 | 450,000.00 |
| Dec 31, 2013 | 487,000.00 |